UK Digital PCR Market (2024-2029)

RESEARCH METHODOLOGY

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global digital PCR (dPCR) and real-time PCR (qPCR) market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the digital PCR (dPCR) and real-time PCR (qPCR) market. The secondary sources used for this study include World Bank, GLOBOCAN, World Health Organization (WHO), Eurostat, International Trade Administration, National Human Genome Research Institute (NHGRI, US), National Institutes of Health (NIH) (US), Institute for Health Metrics and Evaluation (US), US Food and Drug Administration (US FDA), Health Canada, European Medicines Agency (UK), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), European Medicines Agency (EMA), German Cancer Research Center, NHS (UK), Medicines and Healthcare Products Regulatory Agency (UK), Pharmaceuticals and Medical Devices Agency (Japan), Beijing Institute of Genomics (China), Ministry of Science & Technology (India), Ministry of Food and Drug Safety (South Korea), BioPlan Associates, Eurostat, and Factiva, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global digital PCR (dPCR) and real-time PCR (qPCR) market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biotechnology companies, CROs, CMOs, and academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the Asia Pacific, North America, Europe, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the digital PCR (dPCR) and real-time PCR (qPCR) market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

• The key players in the market have been identified through extensive secondary research.
• The revenues generated from the digital PCR (dPCR) and real-time PCR (qPCR) business of leading players have been determined through primary and secondary research to arrive at the overall digital PCR (dPCR) and real-time PCR (qPCR) market.
• All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
• Additionally, to arrive at the digital PCR (dPCR) and real-time PCR (qPCR) market for product segments, the PCR business shares of leading players for separate product category (wherever available) were also gathered from secondary sources. In some instances, the shares of PCR product businesses were ascertained through a detailed analysis of various parameters, including product portfolios, market positioning and primary insights.
• All assumptions, approaches and individual shares/revenue estimates were validated through expert interviews.

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Data Triangulation

After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Polymerase chain reaction (PCR) is a well-established technique used for the in vitro amplification of a given nucleotide (such as DNA). Digital polymerase chain reaction (digital PCR or dPCR) is a third-generation polymerase chain reaction technique that is used to clonally amplify and directly quantify nucleic acid strands, including DNA, cDNA, or RNA. Similarly, quantitative/real-time PCR (qPCR) is a well-established PCR technique that is widely utilized in DNA identification, amplification, and quantification. It involves the real-time analysis of reaction mixtures with the aid of fluorescent markers that are specific to either the end product or the reactant.

Stakeholders

• dPCR and qPCR product manufacturing companies
• Third-party suppliers, direct suppliers, distributors, and channel partners
• Venture capitalists and other public-private funding agencies
• Healthcare service providers (including hospitals and diagnostic centers)
• Pharmaceutical and biotechnology companies
• Academic and research institutes
• CROs & CDMOs
• Forensic laboratories
• Market research and consulting firms
• Government and independent regulatory authorities

Report Objectives

• To define, describe, and forecast the digital PCR (dPCR) and real-time PCR (qPCR) market based on offering, application, end user, and region
• To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
• To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall digital PCR (dPCR) and real-time PCR (qPCR) market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of the market segments with respect to six main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
• To profile the key players in the digital PCR (dPCR) and real-time PCR (qPCR) market and comprehensively analyze their product portfolios, market positions, and core competencies
• To track and analyze competitive developments in the digital PCR (dPCR) and real-time PCR (qPCR) market, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations
• To benchmark players within the digital PCR (dPCR) and real-time PCR (qPCR) market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business strategy and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

• Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

• Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

• A further breakdown of the Rest of Asia Pacific Digital PCR (dPCR) and real-time PCR (qPCR) market into countries
• A further breakdown of the Rest of European Digital PCR (dPCR) and real-time PCR (qPCR) market into countries
• A further breakdown of the Rest of Latin American Digital PCR (dPCR) and real-time PCR (qPCR) market into countries